Genmab

At Society for Immunotherapy of Cancer (SITC) 2024, we presented data evaluating one of our investigational bispecific antibodies in non-small cell lung cancer (NSCLC). We are dedicated to exploring potential treatment options for those living with solid tumors. Learn more about our pipeline: http://gmab.ly/Yor850U58K2. #SITC24 #NSCLC

Our colleague, Petra Evenäs, Director, Clinical Trial Disclosure & Transparency, recently presented at the Clinical Data Disclosure Europe conference in Amsterdam, where she shared insights on a framework to secure commercially confidential information.     By participating in industry forums, our colleagues are contributing towards our commitment to the transparency of clinical trial research.     Learn more: http://gmab.ly/S3y150U57AC.

#InvestorUpdate: We’ve published our Interim Report for the first nine months of 2024.       Hear from Anthony Pagano, Executive Vice President & Chief Financial Officer on our progress toward our goal to impact patients’ lives with antibody medicines.          Read the full report here: https://lnkd.in/eVCkDMxu.  

We are excited to announce that we will be presenting 20+ abstracts for our investigational antibody therapy at the 66th American Society of Hematology Annual Meeting and Exposition. Learn more about our upcoming presentations: http://gmab.ly/x0hI50U0Aw0

We’re gearing up for this year’s Society for Immunotherapy of Cancer (SITC) Annual Meeting to connect with the oncology community and share our latest advancements in antibody science.    To learn more, stop by booth #814 and visit: http://gmab.ly/icRI50TQV63.            #SITC24 #Biotech #Innovation  

Welcome to Genmab’s November Edition of Knock-Your-Socks-Off-News, a monthly newsletter covering our current happenings across the globe. Follow along with us on our journey for more updates as we advance innovation and continue to work towards our goal of transforming the lives of patients through antibody medicines. #culture #news #healthcare

#InvestorUpdate: We’re sharing our interim report for the first nine months of 2024. Tune in to hear more about our recent progress from our CEO & President Jan van de Winkel, Ph.D., EVP & Chief Financial Officer Anthony Pagano and EVP & Chief Commercial Officer Brad Bailey.      To register, visit: http://gmab.ly/O1Ef50TQV38.     #Biotech #Innovation

At Genmab, our colleagues embrace our values of passion for innovation, determination, integrity and working as one team with a common goal of improving the lives of patients. Hear from Abdullah Almiqasbi, Senior Manager, Corporate Planning & Governance and Sayaka Kikuta, Senior Manager, Safety Operations & Data Management on how they experience empowerment in their work. Learn more: http://gmab.ly/Ihwn50TQUXm.  #ExtraNotOrdinary  

As a company rooted deeply in science, we are focused on utilizing the power of Data Science and AI in our daily work to innovate new antibody therapies with the goal of improving the lives of patients.       Roberto Spreafico, Senior Director of Discovery Data Science recently presented at the Antibody Engineering and Therapeutics Asia conference in Japan and shared insights on gathering high-quality, informative data while ensuring experimental feasibility with the goal to empower a de novo antibody design using a ML model. Learn more about our Data Science approach here: http://gmab.ly/8beM50TQUS0.  

Hisham Hamadeh, SVP, Global Head of Data Science & AI, and Bryan Hancsin, Senior Director, US Digital Marketing, recently presented at Reuters Events Pharma’s Customer Engagement USA in two separate panel discussions. Hisham shared insights on leveraging data science and AI and Bryan focused on using omnichannel strategy to enhance customer and patient engagement. Discussing our innovative approaches fosters industry-wide collaboration and challenges us to continuously improve how we work toward our shared goal of making an impact on the lives of patients.     Learn more: http://gmab.ly/YGaC50TQUYH.   #REcustomerUSA #Data #Innovation